NCT03530150View on ClinicalTrials.gov

Pirfenidone and Its Role in Burn Wound Healing

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 22, 2017

Study Completion Date

June 22, 2017

Conditions
Second-degree Burn
Interventions
DRUG

Pirfenidone Oral Product

A pill containing 600 mg of pirfenidone

All Listed Sponsors
lead

Universidad Autonoma de Nuevo Leon

OTHER

NCT03530150 - Pirfenidone and Its Role in Burn Wound Healing | Biotech Hunter | Biotech Hunter